Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population.
about
Congenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and preventionImmunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus modelMolecular Imprint of Exposure to Naturally Occurring Genetic Variants of Human Cytomegalovirus on the T cell RepertoireThe immunological underpinnings of vaccinations to prevent cytomegalovirus disease.Prevalence and risk factors for betaherpesvirus DNAemia in children >3 weeks and <2 years of age admitted to a large referral hospital in sub-Saharan Africa.Cytomegalovirus reinfections in healthy seroimmune women.Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization.Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.Cytomegalovirus seroprevalence in pregnant women and association with adverse pregnancy/neonatal outcomes in Jiangsu Province, China.Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.Cytomegalovirus viruria and DNAemia in healthy seropositive women.Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infectionSeroprevalence of Cytomegalovirus among pregnant women and hospitalized children in PalestineCongenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population.A novel real-time PCR method for determination and quantification of each cytomegalovirus glycoprotein H subtype in clinical samples.Congenital cytomegalovirus infection: clinical outcomePrediction of Maternal Cytomegalovirus Serostatus in Early Pregnancy: A Retrospective Analysis in Western Europe.Maternal and Congenital cytomegalovirus infection and zero rubella IgM prevalence in newborns in St.Paul's Hospital Millennium Medical College.Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D LigandEffect of Mycoplasma hominis and cytomegalovirus infection on pregnancy outcome: A prospective study of 200 Mongolian women and their newborns.Cytomegalovirus Genotype Distribution Among Congenitally and Postnatally Infected Patients: Association of Particular Glycoprotein (g)B and gN Types With Symptomatic Disease.The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?Kinetics of IgG antibody to cytomegalovirus (CMV) after birth and seroprevalence of anti-CMV IgG in Chinese childrenMolecular Detection of Human Cytomegalovirus (HCMV) Among Infants with Congenital Anomalies in Khartoum State, Sudan.The "silent" global burden of congenital cytomegalovirus.A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.Adenovirus E1A/E1B Transformed Amniotic Fluid Cells Support Human Cytomegalovirus Replication.Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom.Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries.Overview of the diagnosis of cytomegalovirus infection.Diagnosis of congenital cytomegalovirus infection in high risk neonatesCytomegalovirus in the neonate: immune correlates of infection and protectionHuman cytomegalovirus (CMV) in Africa: a neglected but important pathogenChanging patterns of cytomegalovirus seroprevalence among pregnant women in Norway between 1995 and 2009 examined in the Norwegian Mother and Child Cohort Study and two cohorts from Sor-Trondelag County: a cross-sectional study.Prevalence and clinical aspects of CMV congenital Infection in a low-income population.Prevalence, Characteristics, and One-Year Follow-Up of Congenital Cytomegalovirus Infection in Isfahan City, Iran.Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?Molecular and biological characterization of a new isolate of guinea pig cytomegalovirus.Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China.Cytomegalovirus in pregnancy and the neonate.
P2860
Q27024030-E06D5230-0944-494D-9B08-DCC8E6DCC043Q27026924-1F75CB06-53B4-4925-B071-626BC1D3D7CBQ27681653-9FFB5C36-E274-45A4-9E83-DBCBBEA6EDA4Q27692570-E054E96F-FCF1-4A47-B160-F4749C7B045BQ30368207-C0D4DF51-D1F1-4D26-885A-3E3D006796ADQ33583493-FF84B664-0F2A-4EB2-B811-8E4C1A50E0CDQ33802555-9A18910A-B2F6-4E28-9CCA-006F0F83896FQ33877783-63F78EB0-8406-455B-BC61-B9FD5555D116Q34166485-C8DF4209-D0CD-4C64-9BB3-B18AB6771A6CQ34289143-B5CCBCED-D5D6-4D2C-88C6-BA356F1DC27FQ34332584-F199F5A9-A743-4FB7-8CB9-0EF2BED76972Q34382541-D0DF811A-3325-4CE2-AAB4-FC55B6261CF6Q35037239-16DC5234-C2BB-4828-BD9C-AD873B4530A9Q35569285-5B86011E-3B5A-467D-AEAE-E724EBB506A7Q35689013-16F90D66-C56D-4E40-A04B-1AA64C3EE02BQ35753496-BFEFE2AE-9C9A-4384-A2F5-711E88D9B76FQ35875262-B55DD45F-D992-4A09-A14B-98FC3BD79064Q36171599-164409B7-53E6-4E7E-92FC-6DF26C2C11D5Q36210368-27132B16-1476-48BA-81EE-BC29AB5340D8Q36296867-1351FE13-B1FC-4045-9EB7-E9790C249ACAQ36302015-5DE0863F-FD11-4107-85BD-79BF0667B2B5Q36302615-812BD0DF-285E-420B-AFE8-2F46E0D89E59Q36531501-2CBE2D7D-578B-4A1D-B171-BA7EBC760580Q36542889-7CF68F6D-26B5-49D9-915F-DD5A22AECC03Q36558293-27FAB0A2-294A-473E-8288-47E12BE8EB35Q36559845-9E8BFB8F-ECE3-4CB0-BB42-2E60BA94C3BDQ36645514-73F371A6-F100-4C0C-A34C-C15C85122E37Q36740234-39111E92-8B2F-47FE-B504-51D63B859BDFQ36792150-633DC7BB-8A48-488A-A15B-4BE7A23BF422Q37062282-599EF613-FD3B-4569-AD7A-102486FDD93BQ37078884-138841CD-85B4-4981-9725-BA8D5F200A2AQ37140130-C9C293EB-E720-48EF-977B-1693A221F692Q37141399-B3906013-F9BE-47BC-8E84-11E43B8911D3Q37208271-0FD78F3F-2AED-4956-9D10-A32B31B0D9F4Q37220902-A5B5855F-96D7-4C35-ADF5-362871A2DF60Q37539062-A07D7275-A8E0-4EB7-8970-688B45A76CD7Q37574334-7A7495B6-AC7E-4646-8FF9-C81109629A97Q37611802-284A93F9-7816-463E-B6C5-3C2D5EB2230AQ37626662-7C89D0E8-0483-4CAC-B831-C81D29519F8EQ37643347-2C8475C5-E7C3-46BD-BE2F-138AF6875189
P2860
Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Birth prevalence and natural h ...... highly seroimmune population.
@en
Birth prevalence and natural h ...... highly seroimmune population.
@nl
type
label
Birth prevalence and natural h ...... highly seroimmune population.
@en
Birth prevalence and natural h ...... highly seroimmune population.
@nl
prefLabel
Birth prevalence and natural h ...... highly seroimmune population.
@en
Birth prevalence and natural h ...... highly seroimmune population.
@nl
P2093
P2860
P356
P1476
Birth prevalence and natural h ...... highly seroimmune population.
@en
P2093
Aparecida Y Yamamoto
Myriam de Lima Isaac
Patricia F de Carvalho e Oliveira
Rosângela M Moura Brito
Suresh Boppana
William J Britt
P2860
P304
P356
10.1086/600882
P407
P577
2009-08-01T00:00:00Z